Biotage AB (publ)
BITGF · OTC
3/31/2025 | 12/31/2024 | 9/30/2024 | 6/30/2024 | |
|---|---|---|---|---|
| Market Cap | $9 | $13 | $15 | $13 |
| - Cash | $0 | $0 | $0 | $0 |
| + Debt | $0 | $0 | $0 | $0 |
| Enterprise Value | $9 | $13 | $15 | $13 |
| Revenue | $0 | $1 | $0 | $1 |
| % Growth | -33.8% | 18.8% | -2.8% | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | 62.9% | 61.9% | 61.8% | 64.3% |
| EBITDA | $0 | $0 | $0 | $0 |
| % Margin | 7.3% | 38.1% | 22.7% | 24.4% |
| Net Income | $0 | $0 | $0 | $0 |
| % Margin | 1% | 27.3% | 9.2% | 9.5% |
| EPS Diluted | 0.05 | 1.98 | 0.56 | 0.6 |
| % Growth | -97.5% | 253.6% | -6.7% | – |
| Operating Cash Flow | $0 | $0 | $0 | $0 |
| Capital Expenditures | -$0 | -$0 | -$0 | -$0 |
| Free Cash Flow | $0 | $0 | $0 | -$0 |